Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis
Abstract Background This pairwise meta-analysis determines the difference in bleeding risks associated with the use of novel oral anticoagulants (NOACs) and aspirin. Methods PubMed, the Cochrane Library database, clinicaltrial.gov , and related studies were searched for randomized control trials (RC...
Main Authors: | Xiehui Chen, Weichao Huang, Aimei Sun, Lili Wang, Fanrui Mo, Wenqin Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-021-00322-6 |
Similar Items
-
Management of Peptic Ulcer Bleeding in Patients Taking Aspirin or Anticoagulant
by: Hyo-Joon Yang
Published: (2020-11-01) -
Gastrointestinal bleeding risk of non-vitamin K antagonist oral anticoagulants versus warfarin in general and after polypectomy: a population-based study with propensity score matching analysis
by: Jong Yop Pae, et al.
Published: (2022-10-01) -
Re-bleeding and all-cause mortality risk in non-variceal upper gastrointestinal bleeding: focusing on patients receiving oral anticoagulant therapy
by: Won Shik Kim, et al.
Published: (2023-12-01) -
Reduced risk of gastrointestinal bleeding associated with eupatilin in aspirin plus acid suppressant users: nationwide population-based study
by: Hyun Seok Lee, et al.
Published: (2024-03-01) -
Association between eupatilin and reduction in small bowel bleeding in aspirin users and aspirin plus acid suppressant users
by: Hyun Seok Lee, et al.
Published: (2023-07-01)